Sarilumab for the treatment of rheumatoid arthritis.

@article{Cooper2016SarilumabFT,
  title={Sarilumab for the treatment of rheumatoid arthritis.},
  author={Simon Cooper},
  journal={Immunotherapy},
  year={2016},
  volume={8 3},
  pages={249-50}
}
Simon Cooper has >18 years of global experience in the pharmaceutical industry. He joined Sanofi in July 2014 as the Vice President, Global Project Head. In his current position at Sanofi, Dr Cooper is responsible for the clinical development of sarilumab and the worldwide submission in rheumatoid arthritis. He joined Sanofi after serving as the Global Program Medical Director at Novartis since 2012. In this role, Dr Cooper acted as the clinical lead for secukinumab psoriasis submission. Prior… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS